tiprankstipranks
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market
GDTC
CytoMed Therapeutics Limited
RESEARCH TOOLSreports

CytoMed Therapeutics Limited (GDTC) Income Statement

23 Followers

CytoMed Therapeutics Limited Income Statement

Last quarter (Q4 2025), CytoMed Therapeutics Limited's total revenue was $130.63K, an increase of 58.01% from the same quarter last year. In Q4, CytoMed Therapeutics Limited's net income was $-1.35M. See CytoMed Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 248.27K$ 52.01K$ 290.56K$ 0.00$ 84.18K
Gross Profit
$ -689.55K$ 52.38K$ 381.92K$ -81.03K$ 81.59K
Operating Expenses
$ 2.83M$ 1.87M$ 1.58M$ 1.62M$ 937.15K
Depreciation and Amortization
$ 173.58K$ 91.59K$ 77.47K$ 293.32K$ 243.92K
EBITDA
$ -3.34M$ -1.79M$ -2.94M$ -1.10M$ -1.05M
Operating Income
$ -3.52M$ -2.63M$ -3.20M$ -1.70M$ -1.40M
Other Income/Expenses
$ 456.80K$ 739.13K$ 122.21K$ -572.86K$ -128.34K
Pretax Income
$ -3.06M$ -1.89M$ -3.08M$ -2.27M$ -1.53M
Net Income
$ -3.05M$ -1.88M$ -3.13M$ -2.27M$ -1.53M
Per Share Metrics
Basic EPS
$ -0.26$ -0.16$ -0.29$ -0.30$ -0.22
Diluted EPS
$ -0.26$ -0.16$ -0.29$ -0.30$ -0.22
Weighted Average Shares Outstanding
 11.65M 11.54M 10.63M 7.92M 6.93M
Weighted Average Shares Outstanding (Diluted)
 11.65M 11.54M 10.63M 7.92M 6.93M
Currency in USD

CytoMed Therapeutics Limited Earnings and Revenue History